보령

003850KOSPI

61.4 / 100

Reference Date: 2026-09-08

Financial Score25.0 / 40

News Sentiment17.4 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Roughly flat over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Boehringer focuses on strengthening its own product portfolio and building a stable portfolio centered on chronic diseases to enhance profitability. In 2024, the company achieved sales of 1.171 trillion KRW and operating profit of 70.5 billion KRW. It leverages manufacturing competitiveness, R&D capabilities, sales and marketing strength, and the LBA strategy to maintain global market competitiveness.

Number of Employees

1,645people

Average Salary

72.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

11.42Industry Average 15.005.0Point

In line with industry avg

PBR

0.89Industry Average 1.205.5Point

Lower than industry avg (good)

ROE

7.89Industry Average 8.002.5Point

Below industry avg

Debt Ratio

33.99Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲9.2% (2-year basis)

Operating Profit Growth Rate

0.5 / 3

Avg ▼2.2% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 8.6% (improving, 3yr)

Detailed News Sentiment

10 totalPositive 5Neutral 4Negative 1Average Sentiment Score 69.5

Positive
일동제약, 14% 급등…특허 판결에 비만약 기대도 재부각 [바이오 맥짚...
일동제약의 특허 판결로 인해 비만약 관련 기대감이 재부각되어 주가가 급등했다.
Positive
부민병원, 항암신약 벤처 셀랩메드 인수
부민병원의 셀랩메드 인수로 첨단 항암 치료제 개발 역량 강화 및 사업 확장 기대.
Positive
[단독] 부민병원家-빅무브벤처스, 유영제약 '항암신약 벤처' 인수[f...
부민병원그룹의 바이오벤처 인수로 보령의 첨단 바이오 의약품 사업 확장 기대

Detailed Momentum

52-week position3.0Point

52w lower range (37%)

Current 8,750Won52-week high 10,68052-week low 7,570

1-month return3.0Point

1m -0.57% (flat)

Volume trend3.0Point

Volume flat

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral공정거래자율준수프로그램운영현황(안내공시)2026-08-26
Neutral기업설명회(IR)개최(안내공시)2026-08-19
Neutral반기보고서 (2026.06)2026-08-14